Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Dual and Triple Agonist Medications The field is evolving rapidly
Currently, the respective contributions of alcohol and metabolic factors to liver disease are not elucidated in this population
Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss
Our physicians design your protocol, review your labs, and adjust your treatment personally
Chronic or recurring injury patterns may warrant ongoing maintenance protocols at reduced doses
Thoughtful development not only improves the stability and effectiveness of the formula but also strengthens the brands long-term reputation
